Novartis Gets Injunction Against Teva

A New Jersey jury has found in favor of Novartis AG and against Teva Pharmaceuticals USA Inc. on Wednesday in suit that Novartis filed claiming Teva infringed the patent for its genital herpes drug Famvir by seeking regulatory approval to market its own generic version.

This entry was posted on Sunday, November 22nd, 2009 at 10:49 am and is filed under infringement, Intellectual Property, Patents, pharmaceuticals, pharmaceuticals and Biotechnology, Teva, US. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply

Fill in your details below or click an icon to log in:

Gravatar
WordPress.com Logo

Please log in to WordPress.com to post a comment to your blog.

Twitter picture

You are commenting using your Twitter account. ( Log Out / Change )

Facebook photo

You are commenting using your Facebook account. ( Log Out / Change )

Cancel

Connecting to %s

Follow

Get every new post delivered to your Inbox.

Join 92 other followers